As of 2025-09-19, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 12.8x | 10.8x |
| Forward P/E multiples | 11.9x - 16.0x | 13.9x |
| Fair Price | (102.40) - (110.00) | (106.42) |
| Upside | -202.4% - -210.0% | -206.4% |
| Date | EV/EBITDA |